Tricyclic heteroaryl piperazine, pyrrolidine and azetidine as serotonin receptor modulators
PK140908AUndetermined Publication Date: 2010-09-23ATHERSYS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200500822
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-09-23
Abstract
The present invention 140908 relates to a compound of hexahydroazepinoindole and octahydroazepinoindole having formula: this compound is serotonin receptor (5-HT) ligand and is useful for treating disease, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).
Need to check novelty before this filing date? Find Prior Art